Novel treatment options for kidney cancer presented at ASCO 2017
The following video is an interview between PracticeUpdate and Dr Bradley [...]
16-gene recurrence score for high-risk kidney cancer offers prognostic value
Results from a phase III trial presented at the American [...]
Adjuvant pazopanib reduces risk of recurrence after nephrectomy in people with locally advanced kidney cancer
Results from the PROTECT clinical trial, a phase III trial [...]
Adjuvant therapy for high-risk localised kidney cancer
This literature review was published in The Journal of Urology [...]
Neoadjuvant and adjuvant therapy for kidney cancer
A comprehensive review of neoadjuvant therapy and adjuvant therapy for [...]
European guidelines for the treatment of kidney cancer have been updated
The European Association of Urology (EAU) Renal Cell Carcinoma (RCC) [...]
Adjuvant sunitinib or sorafenib don’t prevent recurrence of kidney cancer
Results from the ASSURE clinical trial have recently been published [...]
Immunotherapy before and after surgery for kidney cancer
At the American Urological Association's Annual Meeting in San Diego [...]
Adjuvant sunitinib or sorafenib for high risk kidney cancer
A study published in The Lancet last week reported that [...]
